Health
New strategic collaboration to accelerate treatments for unmet medical needs in oncology – News-Medical.Net
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with bra…
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
This collaboration will bring Taiho’s unique portfolio of preclinical and clinical brain-penetrant therapies together wit…
-
General16 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business16 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General17 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General19 hours agoAlbanese beats drum on economy as trade clouds gather